Photo (L-R): Gynecologic Oncologist Dr. Ernst Lengyel, Oncologist & Medical Director of Gynecologic Oncology Dr. Gini Fleming, & Obstetrician-Gynecologist Dr. Iris Romero
Romero Research Program: Cancer Prevention
A large part of Dr. Romero’s clinical research work focuses on cancer prevention. As a member of the Stand Up 2 Cancer Ovarian Dream team, Dr. Romero contributes to studies focused on optimizing ovarian cancer prevention strategies and studies evaluating novel approaches to increasing access to genetic testing. She also collaborates on clinical research aimed at optimizing breast cancer prevention for minority populations. This work has included clinical trials testing breast MRI screening protocols for high-risk populations.
- Guindalini RSC, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova G, Liu F, Raoul A, Cao H, Romero IL, Hong S, Livingston RJ, Jaskowiak N, Wang X, Debiasi M, Pritchard CC, King MC, Karczmar G, Newstead GM, Huo D, and Olopade OI. Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers. Clinical Cancer Research. 2019 Mar15;25(6):1786-1794. PMID: 30154229.
- Nielsen S, De Nicolo A, Eccles D.M., Romero IL, Al-Mulla F, Blok R, Chan C, Claes K, de la Hoya M, Diaz O, Domchek S, Eels R, Efrewidis A, ENIGMA, Fostira F, Goldgar D, Gutierrez S, Hadjisavvas M, van Overeen-Hansen T, Hirasawa A, Houdayer C, Hriger S, Kleibova P, Lazaro C, Weitzel J, Olopade O, Spurdle AB, Gómez-García E et al. Genetic testing and clinical management practices for variants in non-BRCA1/2 candidate breast (or Ovarian) cancer susceptibility genes: An international survey from the ENIGMA clinical working group. Journal of Clinical Oncology- Precision Medicine. 2018 June 1(15):1539. PMID: 31517176.
- Rayes N, Bowen DJ, Coffin T, Nebgen D, Peterson C, Munsell MF, Gavin K, Lechner R, Crase J, Polinsky D, Romero I, Blank SV, Levine DA, Norquist BM, and Lu KH. MAGENTA (Making Genetic testing accessible): A prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing. BMC Cancer 2019 19:648. PMID: 31266460.